Insider · CIK 0001730336
Lawrence Bruno
Files at CLB (Core Laboratories Inc. /DE/). First filing Aug 4, 2026, latest Aug 4, 2026.
In brief
Lawrence Bruno files SEC Form 4 as CEO, chair and director at CLB (Core Laboratories Inc. /DE/). Since Aug 4, 2026, Lawrence Bruno has reported 1 open-market buy worth $54k and 0 open-market sells worth $0, the latest filed on Aug 4, 2026.
A track record needs three past buys with six months of prices behind them; Lawrence Bruno has 0, so none is measured yet.
The newest scored trade: bought $54k of CLB on Jul 31, 2026, filed Aug 4, 2026, scored 32 (weak). In the last 12 months: 1 buy worth $54k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CLB: Core Laboratories Inc. /DE/
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | CLBbuy Core Laboratories Inc. /DE/ | $54k 5,000 shares | +2% | - |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | CLB Core Laboratories Inc. /DE/ | POpen-market purchase Common Stock | +5,000 | $10.78 | $54k | 262,438 | Aug 4, 2026 |
| Feb 12, 2026 | CLB Core Laboratories Inc. /DE/ | AGrant or award Performance Sharesderivative | +204,340 | $0.00 | $0 | 204,340 | Feb 17, 2026 |
| Dec 31, 2025 | CLB Core Laboratories Inc. /DE/ | FTax withholding Common Stock | -112,681 | $16.03 | $1.8M | 257,438 | Jan 5, 2026 |
| Dec 31, 2025 | CLB Core Laboratories Inc. /DE/ | MOption exercise Common Stock | +180,722 | $0.00 | $0 | 370,119 | Jan 5, 2026 |
| Dec 31, 2025 | CLB Core Laboratories Inc. /DE/ | MOption exercise Performance Sharesderivative | -180,722 | $0.00 | $0 | 0 | Jan 5, 2026 |
| Feb 13, 2025 | CLB Core Laboratories Inc. /DE/ | AGrant or award Performance Sharesderivative | +202,764 | $0.00 | $0 | 202,764 | Feb 13, 2025 |
| Dec 31, 2024 | CLB Core Laboratories Inc. /DE/ | FTax withholding Common Stock | -43,380 | $17.31 | $751k | 189,397 | Jan 3, 2025 |
| Dec 31, 2024 | CLB Core Laboratories Inc. /DE/ | MOption exercise Common Stock | +69,574 | $0.00 | $0 | 232,777 | Jan 3, 2025 |
| Dec 31, 2024 | CLB Core Laboratories Inc. /DE/ | MOption exercise Performance Sharesderivative | -69,574 | $0.00 | $0 | 0 | Jan 3, 2025 |
Questions about Lawrence Bruno
Answered from the filings on this page, as of the latest one.
Is Lawrence Bruno buying or selling?
In the last 12 months Lawrence Bruno reported 1 open-market buy worth $54k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $54k of CLB on Jul 31, 2026. Grants, option exercises and tax withholding are not counted.
How did Lawrence Bruno's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lawrence Bruno has 0.
Where does Lawrence Bruno file Form 4?
Lawrence Bruno has filed Form 4 at CLB (Core Laboratories Inc. /DE/) as Chairman and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.